Insulin Receptor Substrate 1 Gene Variation Modifies Insulin Resistance Response to Weight-Loss Diets in a 2-Year Randomized Trial

Author:

Qi Qibin1,Bray George A.1,Smith Steven R.1,Hu Frank B.1,Sacks Frank M.1,Qi Lu1

Affiliation:

1. From the Departments of Nutrition (Q.Q., F.B.H., F.M.S., L.Q.) and Epidemiology (F.B.H.), Harvard School of Public Health and the Channing Laboratory (F.B.H., F.M.S., L.Q.), Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA; Pennington Biomedical Research Center of the Louisiana State University System, Baton Rouge, LA (G.A.B.); and Translational Research Institute for Metabolism and Diabetes, Winter Park, FL (S.R.S.).

Abstract

Background— Common genetic variants in the insulin receptor substrate 1 ( IRS1 ) gene have been recently associated with insulin resistance and hyperinsulinemia. We examined whether the best-associated variant modifies the long-term changes in insulin resistance and body weight in response to weight-loss diets in Preventing Overweight Using Novel Dietary Strategies (POUNDS LOST) trial. Methods and Results— We genotyped IRS1 rs2943641 in 738 overweight adults (61% were women) who were randomly assigned to 1 of 4 diets varying in macronutrient contents for 2 years. We assessed the progress in fasting insulin, homeostasis model assessment of insulin resistance (HOMA-IR) and weight loss by genotypes. At 6 months, participants with the risk-conferring CC genotype had greater decreases in insulin ( P =0.009), HOMA-IR ( P =0.015), and weight loss ( P =0.018) than those without this genotype in the highest-carbohydrate diet group whereas an opposite genotype effect on changes in insulin and HOMA-IR ( P ≤0.05) was observed in participants assigned to the lowest-carbohydrate diet group. No significant differences were observed across genotypes in the other 2 diet groups. The tests for genotype by intervention interactions were all significant ( P <0.05). At 2 years, the genotype effect on changes in insulin and HOMA-IR remained significant in the highest-carbohydrate diet group ( P <0.05). The highest carbohydrate diet led to a greater improvement of insulin and HOMA-IR ( P for genotype–time interaction ≤0.009) in participants with the CC genotype than those without this genotype across 2-year intervention. Conclusions— Individuals with the IRS1 rs2943641 CC genotype might obtain more benefits in weight loss and improvement of insulin resistance than those without this genotype by choosing a high-carbohydrate and low-fat diet. Clinical Trial Registration— http:www.clinicaltrials.gov . Unique identifier: NCT00072995.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3